✦ LIBER ✦

Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study

✍ Scribed by Y Benhamou; M Bochet; V Thibault; V Calvez; MH Fievet; P Vig; CS Gibbs; C Brosgart; J Fry; H Namini; C Katlama; T Poynard

Book ID: 117278205
Publisher: The Lancet
Year: 2001
Tongue: English
Weight: 97 KB
Volume: 358
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(01)05840-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and efficacy of adefovir dipivoxi

Safety and efficacy of adefovir dipivoxil in patients infected with lamivudine-resistant hepatitis B and HIV-1

✍ Yves Benhamou; Vincent Thibault; Pamela Vig; Vincent Calvez; Anne-Genevieve Marc 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 125 KB

Study on the Efficacy and Safety of Adef

Study on the Efficacy and Safety of Adefovir Dipivoxil Treatment in Post–Liver Transplant Patients With Hepatitis B Virus Infection and Lamivudine-Resistant Hepatitis B Virus

✍ R. Bárcena; S. Del Campo; G. Moraleda; T. Casanovas; M. Prieto; M. Buti; J.M. Mo 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 61 KB

2 Safety and efficacy of adefovir dipivo

2 Safety and efficacy of adefovir dipivoxil in patients with lamivudine-resistant chronic hepatitis B undergoing liver transplantation

✍ E. Schiff; C.L. Lai; P. Neuhaus; H. Tillman; D. Samuel; J.P. Villeneuve; S. Hadz 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 108 KB

Efficacy and safety of adefovir dipivoxi

Efficacy and safety of adefovir dipivoxil 20 mg daily in HBeAg-positive patients with lamivudine-resistant hepatitis B virus and a suboptimal virological response to adefovir dipivoxil 10 mg daily

✍ Christophe Hézode; Stéphane Chevaliez; Magali Bouvier-Alias; Françoise Roudot-Th 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 125 KB

Efficacy and safety of entecavir versus

Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: A randomized, open-label study

✍ Yun-Fan Liaw; Maria Raptopoulou-Gigi; Hugo Cheinquer; Shiv Kumar Sarin; Tawesak 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 436 KB 👁 2 views

A randomized, open-label comparative study of entecavir versus adefovir therapy was performed in subjects with chronic hepatitis B who had hepatic decompensation (Child-Turcotte-Pugh score ≥7). Adult subjects were randomized and treated (n = 191) with entecavir 1.0 mg or adefovir 10 mg daily for up

Adefovir and lamivudine in combination c

Adefovir and lamivudine in combination compared with adefovir monotherapy in HBeAg-negative adults with chronic hepatitis B virus infection and clinical or virologic resistance to lamivudine: A retrospective, multicenter, nonrandomized, open-label study

✍ Adriano M. Pellicelli; Giuseppe Barbaro; Ruggiero Francavilla; Mario Romano; Gio 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 536 KB